NASDAQ: ATYR aTYR PHARMA INC 8-K

aTyr Pharma reports Q1 2026 financial results in routine earnings disclosure

Filed May 15, 2026 · Period ending May 15, 2026 · ~1 min read

1 material change detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade ATYR commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 2, 2026 4:06 PM